LCG
MEDP icon

Lisanti Capital Growth’s Medpace MEDP Stock Holding History

Lisanti Capital Growth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,720
Closed -$708K – 135
2024
Q2 		$708K Sell
1,720
-1,870
-52% -$741K 0.17% 109
2024
Q1 		$1.45M Sell
3,590
-55
-2% -$19.3K 0.35% 92
2023
Q4 		$1.12M Sell
3,645
-10,140
-74% -$2.74M 0.26% 102
2023
Q3 		$3.34M Buy
+13,785
New +$3.53M 0.53% 77
2021
Q4 		– Sell
-13,315
Closed -$2.52M – 135
2021
Q3 		$2.52M Buy
+13,315
New +$2.43M 0.37% 95
2018
Q3 		– Sell
-7,050
Closed -$303K – 148
2018
Q2 		$303K Buy
+7,050
New +$285K 0.12% 134
2017
Q1 		– Sell
-19,481
Closed -$703K – 100
2016
Q4 		$703K Buy
19,481
+2,540
+15% +$84.6K 0.85% 61
2016
Q3 		$506K Buy
+16,941
New +$495K 0.64% 74

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lisanti Capital Growth's MEDP Position: Q3 2024 in Review

Lisanti Capital Growth sold out of Medpace (MEDP) in Q3 2024, closing a stake of 1,720 shares — an estimated $708K sold.

Lisanti Capital Growth first reported a position in MEDP in Q3 2016 and held it in 8 quarters. The position peaked at $3.34M in Q3 2023. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Lisanti Capital Growth reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 1,720 Medpace shares in Q3 2024, an estimated $708K.
  • Lisanti Capital Growth first reported a position in Medpace in Q3 2016 and held it in 8 quarters.
  • Lisanti Capital Growth's Medpace position peaked at $3.34M in Q3 2023.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Lisanti Capital Growth's 13F filing for Q3 2024, filed 4 Nov 2024.